Pharmafile
Therapeutic areas in focus
Precision medicine and targetted solutions can be utilised to treat cancer, but how can this develop in the future?
How can the benefits of immunotherapy be maximised for each patient?
Novartis UK tells Pharmafile how COVID-19 impacted patient access to oncology treatments, and how the pharma industry can support the NHS
The UK has seen many innovations in the healthcare sphere, many have which have been in oncology, but what are the next steps in this ever-evolving field?
Pharmafile speaks to Enara Bio: Enara Bio tell Pharmafile about the unmet patient needs in oncology, and how these can be tackled by novel therapies, as well as considering the future of immunotherapy